EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic cannabinoids in human post-mortem samples – ADB-BUTINACA and metabolites in three fatalities

Annette Zschiesche, Sophia Köpfler, Cora Wunder, Annekathrin M Keiler, Johanna Görg, Cleo P Walz, Barbara Fliss, Tanja Germerott, Volker Auwärter, Laura M Huppertz

Frontiers in Toxicology · 14.05.2026 · 8

DOI: 10.3389/ftox.2026.1826767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Toxicology, online erschienen am 14.05.2026. Verfasst von Annette Zschiesche und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Forensic Medicine, Forensic Toxicology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, …. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The potent synthetic cannabinoid ADB-BUTINACA (also known as ADB-BINACA) was implicated in three fatal intoxications. Post-mortem samples, including femoral and heart blood, urine, gastric content, bile, vitreous humor, cerebrospinal fluid, and various tissues (brain, kidney, liver, lung, muscle), were analyzed. All cases were mixed intoxications with pregabalin, heroin, ketamine, MDPHP, or ethanol.

Methods

Post-mortem examinations were performed in all three fatalities. Blood and urine were screened by immunoassay, gas chromatography-mass spectrometry (GC-MS), and liquid chromatography-tandem mass spectrometry (LC-MS/MS) for drugs. ADB-BUTINACA was quantified by standard addition in all matrices except vitreous humor and cerebrospinal fluid. For assessing the contribution of ADB-BUTINACA, a Toxicological Significance Score (TSS) was assigned to each case. Metabolite profiles received from analysis of post-mortem matrices were compared with HepG2 cell and human liver microsome data. Additionally, compound stability was assessed over 12 weeks in whole blood.

Results

Femoral blood concentrations of ADB-BUTINACA ranged from 4.2–8.2 ng/mL, and in heart blood from 5.7–11 ng/mL. Brain tissue contained 1.0–6.2 ng/g, and vitreous humor 0.33–2.1 ng/mL. TSS for ADB-BUTINACA of 1 – 3 were assigned for all cases. Heart-to-femoral blood ratios (1.3–1.8) indicated relatively low post-mortem redistribution. Metabolite profile assessment indicated that detection of metabolic biomarkers such as the dihydrodiol could be relevant in urine and bile. Matrix storage at −20 °C is highly recommended to avoid stability issues.

Conclusion

ADB-BUTINACA was detected in all investigated matrices, with the highest concentrations observed in liver, lung, and kidney tissue. The elevated levels in these organs likely reflect their lipophilicity as well as their involvement in absorption (lungs) and metabolism/excretion processes (liver and kidneys). The results of this study may enhance interpretation of toxicological findings in similar cases.

Schlagwörter

Stichwörter der Autor:innen

HepG2 cellsbrain tissuecerebrospinal fluidfatal intoxicationsnew psychoactive substances (NPS)synthetic cannabinoid receptor agonist (SCRA)toxicological significance score (TSS)vitreous humor

Autor:innen und Institutionen

  • Institute of Forensic Medicine, Forensic Toxicology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Hermann Staudinger Graduate School, University of Freiburg, Freiburg, Germany.
  • Furtwangen University of Applied Sciences, Furtwangen, Germany.
  • Institute of Legal Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Faculty of Biology, Environmental Monitoring and Endocrinology, TU Dresden University of Technology, Dresden, Germany.

Zitieren

APA

Zschiesche, A., Köpfler, S., Wunder, C., Keiler, A. M., Görg, J., Walz, C. P., Fliss, B., Germerott, T., Auwärter, V., & Huppertz, L. M. (2026). Synthetic cannabinoids in human post-mortem samples – ADB-BUTINACA and metabolites in three fatalities. Frontiers in Toxicology, 8. https://doi.org/10.3389/ftox.2026.1826767

Vancouver

Zschiesche A, Köpfler S, Wunder C, Keiler AM, Görg J, Walz CP, et al. Synthetic cannabinoids in human post-mortem samples – ADB-BUTINACA and metabolites in three fatalities. Frontiers in Toxicology. 2026;8. doi:10.3389/ftox.2026.1826767

BibTeX
@article{Zschiesche2026,
  author = {Zschiesche, Annette and Köpfler, Sophia and Wunder, Cora and Keiler, Annekathrin M and Görg, Johanna and Walz, Cleo P and Fliss, Barbara and Germerott, Tanja and Auwärter, Volker and Huppertz, Laura M},
  title = {Synthetic cannabinoids in human post-mortem samples – ADB-BUTINACA and metabolites in three fatalities},
  journal = {Frontiers in Toxicology},
  year = {2026},
  volume = {8},
  doi = {10.3389/ftox.2026.1826767}
}
Kostenlos starten →